Homoharringtonine Clinical Trials
5 recruitingDrug
Phase 23Phase 33
Showing 1–5 of 5 trials
Recruiting
Phase 2
HAV Versus DAV/IAV Induction Regimen in Elderly Patients With AML
AML
Institute of Hematology & Blood Diseases Hospital, China60 enrolled1 locationNCT06744556
Recruiting
Phase 3
Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL
ETP-ALL
First Affiliated Hospital of Zhejiang University81 enrolled1 locationNCT06361329
Recruiting
Phase 3
Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia
Relapsed or Refractory Acute Myeloid Leukemia
Shanxi Bethune Hospital50 enrolled1 locationNCT05726110
Recruiting
Phase 2
Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
Acute Myeloid LeukemiaAML, Childhood
Children's Hospital of Soochow University500 enrolled13 locationsNCT06221683
Recruiting
Phase 2Phase 3
Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University60 enrolled1 locationNCT05805098